EdenTree Asset Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-750
Closed -$437K 74
2023
Q4
$437K Hold
750
0.14% 65
2023
Q3
$403K Hold
750
0.16% 57
2023
Q2
$351K Buy
+750
New +$315K 0.12% 69

Other funds holding LLY

EdenTree Asset Management's LLY Position: Q1 2024 in Review

EdenTree Asset Management sold out of Eli Lilly (LLY) in Q1 2024, closing a stake of 750 shares — an estimated $437K sold.

EdenTree Asset Management first reported a position in LLY in Q2 2023 and held it in 3 quarters. The position peaked at $437K in Q4 2023. 3,460 funds tracked by Wall St. Rank hold LLY as of Q1 2024.

  • EdenTree Asset Management reported no remaining Eli Lilly position as of Q1 2024 after selling out during the quarter.
  • EdenTree Asset Management sold 750 Eli Lilly shares in Q1 2024, an estimated $437K.
  • EdenTree Asset Management first reported a position in Eli Lilly in Q2 2023 and held it in 3 quarters.
  • EdenTree Asset Management's Eli Lilly position peaked at $437K in Q4 2023.
  • 3,460 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2024.

Based on EdenTree Asset Management's 13F filing for Q1 2024, filed 15 May 2024.